> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Teva Recalls 1 Lot of Anagrelide Capsules
- URL: https://www.fdaweb.com/teva-recalls-1-lot-of-anagrelide-capsules/
- Published: 2022-05-23T12:00:00.000Z
- Updated: 2026-09-14T17:45:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151879

Teva is recalling one lot of anagrelide capsules, USP 0.5 mg, due to dissolution test failure. The company notified customers on 5/11 that the lot was recalled. An FDA [notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-anagrelide-capsules-usp-05-mg-due-dissolution-test?ref=fdaweb.com#recall-announcement) says Teva distributed 4,224 bottles nationwide from 7/30/2020 through 9/02/2020 to its wholesale, distributor, and retail customers. The notice says administration of the product with lower dissolution may result in decreased effectiveness or ineffectiveness of the drug to exert its platelet-reducing effect.